EDN1 and hypertensive disorder: Pathological conditions (e.g., hypertension) induce endothelial endothelin-1 (ET-1) overexpression, which activates the cardiomyocyte CaMKII/NFATc3 pathway through ETA receptors, driving pathological hypertrophy (Al-Khatib et al., 2018).